Cancer Prevention Group Blog

Cancer Prevention Group Blog

Research Today, Cancer Prevention Tomorrow

cervix

Towards cervical cancer elimination: DNA methylation as a triage strategy

October 21, 2020 Guest Author 0

Today we discuss with Professor Gloria I. Sanchez her latest research into DNA methylation as a triage strategy for women testing HPV positive at the […]

Finding the optimal HPV test for primary screening and triage in Latin America

September 11, 2020 Guest Author 0

In this blog, we speak to Dr Maribel Almonte Pacheco, Prevention and Implementation Group Head at IARC. Dr Almonte is the chief investigator on the […]

Over 99.5% of young women survive following a diagnosis of IA cervical cancer

September 4, 2020 Alejandra Castanon 0

The earliest stage of cervical cancer (known as micro-invasive or stage IA) is treated with minimally-invasive fertility-preserving surgery, often as an outpatient. In fact, very […]

From theory to practice: HPV testing in cervical screening really does work!

February 7, 2019 Alejandra Castanon 4

After months of eager anticipation, the results from the English HPV implementation pilot have been published. Compared to current screening HPV testing detected 50% more […]

To tell or not to tell – what should we do?

May 29, 2018 Peter Sasieni 1

The clinical director of the Irish national cervical screening programme Ireland, Dr Grainne Flannelly, resigned at the end of April. It was revealed that she […]

Is it safe to export cancer screening?

May 23, 2018 Peter Sasieni 1

A woman in the Republic of Ireland, Vicky Phelan, recently settled with a laboratory in America receiving $2.5million compensation for them missing abnormalities on her […]

Welcome to the King’s Cancer Prevention blog

This blog is supported by the Cancer Research UK Cambridge Centre Early Detection Programme

Cancer Prevention: About us

We are a group of epidemiologists and population researchers studying the causes of or early events in the development of cancer. Our aim is to be able to interfere and prevent cancer or diagnose it whilst still easy to treat.

Contact us at cancerprev@kcl.ac.uk

Follow us on Social Media

 

TWITTER FEED

Tweets by CancerPrev_KCL

Latest Posts, Tags & Comments
  • Bowel cancer surveillance for high-risk patients in the time of COVID-19: What have we learned?
  • Headline findings of the BEST3 Trial
  • Beyond trust: collective understanding of the common good and patient data
  • Medical research and the double-edged sword of data protection
  • Medical research and the common law of confidentiality
  • Can prediction models reduce racial/ethnic disparities in lung screening eligibility criteria?
  • Cancer Prevention Group’s 2020 Christmas reading list
  • An interview with: Dr Stuart Griffiths, Director of Research & Services at Yorkshire Cancer Research
  • Achieving cervical cancer elimination requires collective action from civil society
  • In memory of Louise Cadman
Barrett’s oesophagus Best 3 cancer prevention cancer screening cervical cancer cervical screening cervix Clinical research network COVID-19 Cytosponge™ ethics five minutes with HPV HPV primary screening mammography medical research Oesophageal cancer public health public policy quality assurance Sasieni scandal screening sensitivity Upper GI
  • Betty Lakop: I had the privilege of working with Louise in colposcopy clinic in St. Marys Hospital. What I will never forget…
  • Pink Promise India: Great share! Totally agree with you. Early detection of breast cancer through mammography screening leads to numerous treatment options as…
  • Beyond trust: collective understanding of the common good and patient data – Cancer Prevention Group Blog: […] the previous post, we mentioned Use My Data and Understanding Patient Data as examples of efforts to bring […]
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Copyright © 2021 | WordPress Theme by MH Themes